Bob Oliver - 13 Feb 2026 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Feb 2026, 20:48:57 UTC
Prior SEC filing
19 Nov 2025
Next SEC filing
29 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nina Ayer, Attorney in Fact

Key filing fact

Bob Oliver filed Form 4 for EXELIXIS, INC. (EXEL) on 18 Feb 2026.

Key facts

  • This page summarizes Bob Oliver's Form 4 filing for EXELIXIS, INC. (EXEL).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Feb 2026, 20:48.

Change

  • Previous filing in this sequence was filed on 19 Nov 2025.
  • Current net transaction value: -$1,150,123.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001694534 Primary reporting owner

Oliver Bob

Relationship
Director
Address
C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA
Signature
/s/ Nina Ayer, Attorney in Fact
Signature date
18 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXEL transaction

Common Stock

Options Exercise

Transaction value
$175,217
Shares
+9,088
Change %
+21%
Price
$19.28
Shares after
51,370
Date
13 Feb 2026
Ownership
Direct
Footnotes
F1
EXEL transaction

Common Stock

Sale

Transaction value
$396,328
Shares
-9,088
Change %
-18%
Price
$43.61
Shares after
42,282
Date
13 Feb 2026
Ownership
Direct
Footnotes
F1
EXEL transaction

Common Stock

Sale

Transaction value
$929,012
Shares
-21,162
Change %
-50%
Price
$43.90
Shares after
21,120
Date
13 Feb 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXEL transaction Derivative

Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-9,088
Change %
-43%
Price
$0.000000
Shares after
12,118
Date
13 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,088
Exercise price
$19.28
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Footnote F2

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.90 to $43.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

Footnote F3

The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .